SQUID biosusceptometry in the measurement of hepatic iron
- 191 Downloads
Individuals with primary or secondary abnormalities of iron metabolism, such as hereditary hemochromatosis and transfusional iron loading, may develop potentially lethal systemic iron overload. Over time, this excess iron is progressively deposited in the liver, heart, pancreas, and other organs, resulting in cirrhosis, heart disease, diabetes and other disorders. Unless treated, death usually results from cardiac failure. The amount of iron in the liver is the best indicator of the amount of iron in the whole body. At present, the only sure way to measure the amount of iron in the liver is to remove a sample of the liver by biopsy. Iron stored in the liver can be magnetized to a small degree when placed in a magnetic field. The amount of magnetization is measured by our instrument, called a superconducting quantum interference device (SQUID) susceptometer. In patients with iron overload, our previous studies have shown that magnetic measurements of liver iron in patients with iron overload are quantitatively equivalent to biochemical determinations on tissue obtained by biopsy. The safety, ease, rapidity, and comfort of magnetic measurements make frequent, serial studies technically feasible and practically acceptable to patients.
KeywordsIron overload Non-invasive measurement Magnetic susceptibility SQUID
The author wishes to thank Christopher J. Allen, and Drs. Gary M. Brittenham and David E. Farrell for their help with the preparation of this manuscript.
- 2.Farrell DE, Tripp JH, Zanzucchi PE, et al (1980) Magnetic measurement of human iron stores. IEEE Trans Magnetics 16:818–823Google Scholar
- 3.Farrell DE, Tripp JH, Zanzucchi PE, et al (1981) An application of superconductivity to medical diagnostics. Appl Phys Commun 1:1–7Google Scholar
- 5.Farrell DE (1983) Assessment of iron in human tissue: the magnetic biopsy. In: Williamson SJ, Romani GL, Kaufman L (eds) Biomagnetism: an interdisciplinary approach. Plenum Press, New York, p 483Google Scholar
- 6.Fischer R (1998) Liver iron susceptometry. In: Andra W, Nowak H (eds) Magnetism in medicine: a handbook. Wiley-VCH, Berlin, pp 286–301Google Scholar
- 10.Brittenham GM, Sheth S, Allen CJ, et al (2001) Non-invasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 38 [Suppl 1]:37–56Google Scholar
- 14.Piga A, Galanello R, Cappellini MD, et al (2002) Phase II study of oral chelator ICL670 in thalassaemia patients with transfusional iron overload: efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) after 6 months of therapy (abstract). Blood 100[Suppl1]:5aGoogle Scholar
- 17.Brittenham GM, Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK Workshop. Blood 101:15–19Google Scholar
- 18.Kumar S, Avrin WF (1999) A low-cost biomagnetic susceptometer based on room-temperature sensors. In: Yoshimoto T, Kotani M, Kuriki S, Karibe H, Nakasato N (eds) Recent advances in biomagnetism. Proceedings of the 11th International Conference on Biomagnetism. Tohoku University Press, Sendai, pp 1160–1109Google Scholar
- 20.Farrell DE, Allen CJ, Arendt PN, et al (1999) High Tc susceptometry. Am Phys Soc Abstr VC07.03Google Scholar